Featured Research

from universities, journals, and other organizations

Nutritional Supplement Could Improve Clinical Situation Of ICU Patients

Date:
June 5, 2008
Source:
University of Granada
Summary:
For the first time, it has been determined the exact quantity of vitamins A, E and C and minerals needed to improve the clinic situation of critical patients. This study suggests that the oxide stress increase during patients stays in the Intensive Care Unit is due to the low levels of antioxidant food consumption.

UGR News Scientists from the University of Granada and the Virgen de las Nieves University Hospital have found out that some critical patients could improve their oxide stress and, consequently, their clinical situation by taking a simple exogenous antioxidant treatment through food. This study suggests that the oxide stress increase during patients stays in the Intensive Care Unit (ICU) is due to the low levels of antioxidant food consumption.

The oxide stress is caused by the imbalance between the reactive oxygen substances production and the organism defence mechanisms which acts rapidly in the detoxification of these substances or repairs the damage. The oxide stress is involved in many diseases like atherosclerosis, Parkinson, Alzheimer, and it is also significant in the aging process.

This study made by the University of Granada has been carried out by Jimena Abilιs, and headed by doctor Elena Planells (Departament of Physiology of the University of Granada), doctor Antonio Pιrez de la Cruz (head of the Nutrition and Dietetics Unit of the Ruiz de Alda Hospital in Granada) and doctor Eduardo Aguayo (specialist in the Intensive Cure Unit of this same hospital).

The scientists worked on 60 patients that, for at least a week, had stayed at the Intensive Cure Unit (ICU) of the Virgen de las Nieves Hospital, analyzing their oxide stress levels. They determined, for the first time in Spain, the exact quantity of each type of vitamins (A, E and C) and minerals that patients needed to take through diet for proper antioxidant defences.

The researchers hope the study will be useful to establish new recommendations for critical patients in Spain. The results of this investigation have been recently published in the medical journal Critical Care.


Story Source:

The above story is based on materials provided by University of Granada. Note: Materials may be edited for content and length.


Cite This Page:

University of Granada. "Nutritional Supplement Could Improve Clinical Situation Of ICU Patients." ScienceDaily. ScienceDaily, 5 June 2008. <www.sciencedaily.com/releases/2008/06/080604101536.htm>.
University of Granada. (2008, June 5). Nutritional Supplement Could Improve Clinical Situation Of ICU Patients. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2008/06/080604101536.htm
University of Granada. "Nutritional Supplement Could Improve Clinical Situation Of ICU Patients." ScienceDaily. www.sciencedaily.com/releases/2008/06/080604101536.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins